Kabul (AFP) — Afghanistan’s decision to overhaul its medicine market was meant to improve quality and boost domestic production, but industry specialists say the swift changes have led to a litany of problems.

The Taliban authorities announced in November that the decades-long dependency on medicine imports from Pakistan would soon end, a step taken after deadly border clashes with their neighbor.

After the ban came into effect this month, finance ministry spokesman Abdul Qayoom Naseer told AFP that the government urged all importers to find “alternative and legal” sources to replace Pakistani supplies.

Despite a three-month grace period to end existing contracts and clear customs, the shift presents a huge challenge for a country which had imported more than half its medicine from Pakistan.

“Some of the prices have increased, some of them are short (unavailable), it has created a lot of problems for people,” said Mujeebullah Afzali, a pharmacist in the capital, Kabul.

Drugs now have to come from elsewhere, increasing transit time and transport costs, and adding logistical complexities.

The pharmacist said he had begun importing medicine through the Islam Qala crossing on the Iranian border, “which increased the transportation fee 10 to 15 percent.”

Transport costs used to account for six to seven percent of total spending on medicine, but this has now risen to 25 to 30 percent, said a person directly involved in the pharmaceutical industry, speaking to AFP on condition of anonymity due to security concerns.

He estimated that the overall losses to business owners had already reached millions of dollars.